The funds come from every category that carries the theme. A Grade compares a fund only with the other funds in its category, so each category below keeps its own ranking.
Biotech & Genomics
Full Biotech & Genomics ranking| Out of 100, scored against the other funds in this category. A is 70 and up, B 55, C 40, D 25. | Shares traded a day, averaged over the last 30 days. | Average return a year over the last three years. | The largest fall from a peak to the low that followed, over up to five years. | ||||||
|---|---|---|---|---|---|---|---|---|---|
| XBIState Street SPDR S&P Biotech ETF | State Street SPDR S&P Biotech ETFSPDR | XBI State Street SPDR S&P Biotech ETFA | 79 | 0.35% | $9.82B | 8.84M | +27.0% | +26.2% | −48.9% |
| IBBQInvesco Nasdaq Biotechnology ETF | Invesco Nasdaq Biotechnology ETFInvesco | IBBQ Invesco Nasdaq Biotechnology ETFA | 78 | 0.19% | $127M | 41.1K | +26.4% | +23.5% | −30.0% |
| BBPVirtus Biotech ETF | Virtus Biotech ETFVirtus | BBP Virtus Biotech ETFA | 76 | 0.34% | $129M | 11.6K | +27.3% | +26.1% | −32.7% |
| IBBiShares Biotechnology ETF | iShares Biotechnology ETFiShares | IBB iShares Biotechnology ETFA | 74 | 0.44% | $10.8B | 1.67M | +25.5% | +20.9% | −32.1% |
| BBHVanEck Biotech ETF | VanEck Biotech ETFVanEck | BBH VanEck Biotech ETFA | 71 | 0.35% | $527M | 11.2K | +32.0% | +19.0% | −33.1% |
| FBTFirst Trust NYSE Arca Biotechnology Index Fund | First Trust NYSE Arca Biotechnology Index FundFirst Trust | FBT First Trust NYSE Arca Biotechnology Index FundB | 63 | 0.55% | $3.04B | 74.5K | +33.3% | +24.4% | −24.7% |
| IDNAiShares Genomics Immunology and Healthcare ETF | iShares Genomics Immunology and Healthcare ETFiShares | IDNA iShares Genomics Immunology and Healthcare ETFB | 56 | 0.47% | $332M | 131K | +50.0% | +26.0% | −63.2% |
| PBEInvesco Biotechnology & Genome ETF | Invesco Biotechnology & Genome ETFInvesco | PBE Invesco Biotechnology & Genome ETFB | 56 | 0.59% | $425M | 25.2K | +25.3% | +20.2% | −29.0% |
| IBRNiShares Neuroscience and Healthcare ETF | iShares Neuroscience and Healthcare ETFiShares | IBRN iShares Neuroscience and Healthcare ETFC | 46 | 0.47% | $8M | 2.89K | +12.0% | +17.1% | −35.4% |
| SBIOALPS Medical Breakthroughs ETF | ALPS Medical Breakthroughs ETFALPS Funds | SBIO ALPS Medical Breakthroughs ETFC | 45 | 0.50% | $181M | 37K | +14.8% | +29.6% | −48.2% |
| GNOMGlobal X Genomics & Biotechnology ETF | Global X Genomics & Biotechnology ETFGlobal X | GNOM Global X Genomics & Biotechnology ETFC | 42 | 0.50% | $115M | 33.3K | +38.5% | +13.2% | −67.5% |
| HELXFranklin Genomic Advancements ETF | Franklin Genomic Advancements ETFFranklin Templeton | HELX Franklin Genomic Advancements ETFC | 41 | 0.50% | $33M | 5.04K | +17.5% | +14.6% | −52.8% |
| GNMXCorgi Genomics & Precision Medicine ETF | Corgi Genomics & Precision Medicine ETFCorgi Funds | GNMX Corgi Genomics & Precision Medicine ETFC | 40 | 0.35% | $1M | 1.78K | —No data | —No data | —No data |
| WDNAWisdomTree BioRevolution Fund | WisdomTree BioRevolution FundWisdomTree | WDNA WisdomTree BioRevolution FundC | 40 | 0.45% | $5M | 2.51K | +36.8% | +14.7% | −53.8% |
| BBCVirtus Biotech Clinical Trials ETF | Virtus Biotech Clinical Trials ETFVirtus | BBC Virtus Biotech Clinical Trials ETFD | 34 | 0.65% | $31M | 27.8K | +24.2% | +29.3% | −67.4% |
| ARKGARK Genomic Revolution ETF | ARK Genomic Revolution ETFARK | ARKG ARK Genomic Revolution ETFD | 32 | 0.75% | $2.21B | 4.33M | +50.7% | +13.7% | −74.2% |
| CANCTema Oncology ETF | Tema Oncology ETFTema | CANC Tema Oncology ETFD | 27 | 0.75% | $207M | 23.6K | +17.8% | +21.1% | −28.0% |
Not graded
Biotech & Genomics funds with no published Grade, and why.
| Ticker | Fund name | Why no Grade |
|---|---|---|
| TDNAT. Rowe Price Biotech ETF | T. Rowe Price Biotech ETFT. Rowe Price | TDNA T. Rowe Price Biotech ETFNot yet graded |
Health Care (Broad)
Full Health Care (Broad) ranking| Out of 100, scored against the other funds in this category. A is 70 and up, B 55, C 40, D 25. | Shares traded a day, averaged over the last 30 days. | Average return a year over the last three years. | The largest fall from a peak to the low that followed, over up to five years. | ||||||
|---|---|---|---|---|---|---|---|---|---|
| PTHInvesco Dorsey Wright Healthcare Momentum ETF | Invesco Dorsey Wright Healthcare Momentum ETFInvesco | PTH Invesco Dorsey Wright Healthcare Momentum ETFC | 50 | 0.60% | $274M | 53.6K | +13.6% | +20.3% | −46.6% |
| FMEDFidelity Disruptive Medicine ETF | Fidelity Disruptive Medicine ETFFidelity | FMED Fidelity Disruptive Medicine ETFC | 48 | 0.50% | $53M | 15.4K | +28.9% | +17.9% | −21.8% |
| HLTHTema Healthcare AI ETF | Tema Healthcare AI ETFTema | HLTH Tema Healthcare AI ETFF | 22 | 0.75% | $10M | 9.86K | —No data | —No data | —No data |
US Active Sector
Full US Active Sector ranking| Out of 100, scored against the other funds in this category. A is 70 and up, B 55, C 40, D 25. | Shares traded a day, averaged over the last 30 days. | Average return a year over the last three years. | The largest fall from a peak to the low that followed, over up to five years. | ||||||
|---|---|---|---|---|---|---|---|---|---|
| LFSCF/M Emerald Life Sciences Innovation ETF | F/M Emerald Life Sciences Innovation ETFEmerald | LFSC F/M Emerald Life Sciences Innovation ETFB | 60 | 0.54% | $120M | 4.44K | +27.1% | —No data | −29.7% |